Orthocell Ltd
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally. It offers Ortho Autologous Chondrocyte Implantation, a cartilage cell therapy for treatment of articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membr… Read more
Orthocell Ltd (OCC) - Total Liabilities
Latest total liabilities as of June 2025: AU$20.67 Million AUD
Based on the latest financial reports, Orthocell Ltd (OCC) has total liabilities worth AU$20.67 Million AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Orthocell Ltd - Total Liabilities Trend (2010–2025)
This chart illustrates how Orthocell Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Orthocell Ltd Competitors by Total Liabilities
The table below lists competitors of Orthocell Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kao Fong Machinery Co Ltd
TWO:4510
|
Taiwan | NT$4.82 Billion |
|
EcoGraf Ltd
F:FMK
|
Germany | €2.76 Million |
|
Shandong Molong Petroleum Machinery Company Limited
PINK:SHANY
|
USA | $1.82 Billion |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
USA | $31.58 Million |
|
Syscom Computer Engineering Co
TW:2453
|
Taiwan | NT$2.76 Billion |
|
MicroPort CardioFlow Medtech Corporation
PINK:MROPF
|
USA | $450.55 Million |
|
icad inc
NASDAQ:ICAD
|
USA | $8.68 Million |
|
Oncolytics Biotech Inc
NASDAQ:ONCY
|
USA | $14.94 Million |
Liability Composition Analysis (2010–2025)
This chart breaks down Orthocell Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 4.47 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Orthocell Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Orthocell Ltd (2010–2025)
The table below shows the annual total liabilities of Orthocell Ltd from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$20.67 Million | -6.40% |
| 2024-06-30 | AU$22.08 Million | -5.86% |
| 2023-06-30 | AU$23.46 Million | -16.20% |
| 2022-06-30 | AU$27.99 Million | +1039.68% |
| 2021-06-30 | AU$2.46 Million | +8.34% |
| 2020-06-30 | AU$2.27 Million | -21.10% |
| 2019-06-30 | AU$2.87 Million | +0.54% |
| 2018-06-30 | AU$2.86 Million | +16.81% |
| 2017-06-30 | AU$2.45 Million | +9.77% |
| 2016-06-30 | AU$2.23 Million | +3.54% |
| 2015-06-30 | AU$2.15 Million | -57.48% |
| 2014-06-30 | AU$5.06 Million | +636.52% |
| 2013-06-30 | AU$687.24K | +100.36% |
| 2011-06-30 | AU$343.00K | +67.32% |
| 2010-06-30 | AU$205.00K | -- |